My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis.

    Grewal J, Kesari S.

    Breast Cancer Res. 2008;10(2):104. Epub 2008 Mar 14.PMID: 18373884 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival.

    Melisko ME, Moore DH, Sneed PK, De Franco J, Rugo HS.

    J Neurooncol. 2008 Jul;88(3):359-65. Epub 2008 Apr 9.PMID: 18398574 [PubMed - indexed for MEDLINE]Related articles

    3.

    Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

    Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

    Breast Cancer Res. 2009;11(1):R11. Epub 2009 Feb 24.PMID: 19239686 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Factors predictive of response to hormone therapy in breast cancer.

    Rastelli F, Crispino S.

    Tumori. 2008 May-Jun;94(3):370-83. Review.PMID: 18705406 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.

    Hines SL, Vallow LA, Tan WW, McNeil RB, Perez EA, Jain A.

    Ann Oncol. 2008 Sep;19(9):1561-5. Epub 2008 Jun 5.PMID: 18534964 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

    Sunami E, Shinozaki M, Sim MS, Nguyen SL, Vu AT, Giuliano AE, Hoon DS.

    Breast Cancer Res. 2008;10(3):R46. Epub 2008 May 16.PMID: 18485221 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prognosis of patients with triple-negative breast cancer and brain metastasis.

    Venkitaraman R, Joseph T, Dhadda A, Chaturvedi A, Upadhyay S.

    Clin Oncol (R Coll Radiol). 2009 Nov;21(9):729-30. Epub 2009 Jul 29. No abstract available. PMID: 19643588 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impact of triple negative phenotype on breast cancer prognosis.

    Kaplan HG, Malmgren JA.

    Breast J. 2008 Sep-Oct;14(5):456-63. Epub 2008 Jul 24.PMID: 18657139 [PubMed - indexed for MEDLINE]Related articles

    9.

    Immunohistochemical profiles of brain metastases from breast cancer.

    Yonemori K, Tsuta K, Shimizu C, Hatanaka Y, Hashizume K, Ono M, Nakanishi Y, Hasegawa T, Miyakita Y, Narita Y, Shibui S, Fujiwara Y.

    J Neurooncol. 2008 Nov;90(2):223-8. Epub 2008 Jul 23.PMID: 18648908 [PubMed - indexed for MEDLINE]Related articles

    10.

    High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

    Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN.

    J Clin Oncol. 2009 Dec 1;27(34):5700-6. Epub 2009 Nov 2.PMID: 19884543 [PubMed - indexed for MEDLINE]Related articles

    11.

    Survival among women with triple receptor-negative breast cancer and brain metastases.

    Dawood S, Broglio K, Esteva FJ, Yang W, Kau SW, Islam R, Albarracin C, Yu TK, Green M, Hortobagyi GN, Gonzalez-Angulo AM.

    Ann Oncol. 2009 Apr;20(4):621-7. Epub 2009 Jan 15.PMID: 19150943 [PubMed - indexed for MEDLINE]Related articles

    12.

    Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.

    Labidi SI, Bachelot T, Ray-Coquard I, Mosbah K, Treilleux I, Fayette J, Favier B, Galy G, Blay JY, Guastalla JP.

    Clin Breast Cancer. 2009 May;9(2):118-21.PMID: 19433393 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

    Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.

    Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.PMID: 19256737 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk factors for brain relapse in HER2-positive metastatic breast cancer patients.

    Duchnowska R, Dziadziuszko R, Czartoryska-Arłukowicz B, Radecka B, Szostakiewicz B, Sosińska-Mielcarek K, Karpińska A, Starosławska E, Kubiatowski T, Szczylik C.

    Breast Cancer Res Treat. 2009 Sep;117(2):297-303. Epub 2009 Jan 7.PMID: 19130219 [PubMed - indexed for MEDLINE]Related articles

    15.

    Re: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

    Howell SJ, Wardley AM, Armstrong AC.

    J Natl Cancer Inst. 2009 Dec 16;101(24):1730; author reply 1730-1. Epub . No abstract available. PMID: 19893007 [PubMed - indexed for MEDLINE]Related articles

    16.

    Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

    Gonçalves A, Deblock M, Esterni B, Tarpin C, Bertucci F, Gilabert M, Charafe-Jauffret E, Jacquemier J, Houvenaeghel G, Extra JM, Viens P.

    Anticancer Drugs. 2009 Nov;20(10):946-52.PMID: 19741502 [PubMed - indexed for MEDLINE]Related articles

    17.

    Brain metastases as late breast cancer relapse. Single institution experience and review of the literature.

    Tomasevic Z, Radosevic-Jelic Lj, Jovanovic D, Milovanovic Z, Tomasevic ZM, Jelic S, Borojevic N.

    J BUON. 2009 Apr-Jun;14(2):225-8.PMID: 19650170 [PubMed - indexed for MEDLINE]Related articles

    18.

    Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.

    Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P.

    Hum Pathol. 2008 Dec;39(12):1809-15. Epub 2008 Aug 19.PMID: 18715613 [PubMed - indexed for MEDLINE]Related articles

    19.

    Predictive markers in breast cancer--the present.

    Payne SJ, Bowen RL, Jones JL, Wells CA.

    Histopathology. 2008 Jan;52(1):82-90. Review.PMID: 18171419 [PubMed - indexed for MEDLINE]Related articles

    20.

    Gamma Knife radiosurgery for brain metastases from primary breast cancer.

    Kased N, Binder DK, McDermott MW, Nakamura JL, Huang K, Berger MS, Wara WM, Sneed PK.

    Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1132-40. Epub 2009 Apr 3.PMID: 19345514 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk